Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
611 - 620 of 892 results
  • Abstract
    Effects of chronic CB1 agonist administration on coping with multiple reward devaluations
    High expression of the cannabinoid CB1 receptor in brain regions significant for emotional learning regulates fear extinction and stress. This experiment examined coping with unexpected reward devaluations following chronic cannabinoid administration. R...
    Nov 11, 2017
  • Abstract
    Cannabinoid/Serotonin interactions in the interoceptive insular cortex in the regulation of LiCl-induced nausea in rats
    Nausea and vomiting are distressing side effects of chemotherapy treatment for cancer. Currently available first-line anti-emetic therapies (in particular 5-HT3 antagonists) have been critical in reducing these side effects, however, nausea in particula...
    Nov 6, 2018
  • Abstract
    Evaluation of the propagation properites of tau species from different disease states in multiple cellular models
    Tauopathies are a group of neurodegenerative diseases classified by the accumulation of tau aggregates in diverse brain areas leading to distinct clinical manifestations. Evidence suggests that the propagation and transmission of tau throughout the brai...
    Nov 13, 2016
  • Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase | Journal of Neuroscience
    A number of recent in vitro studies have described a role for endogenous cannabinoids (“endocannabinoids”) as transsynaptic modulators of neuronal activity in the hippocampus and other brain regions. However, the impact that endocannabinoid signals may have on activity-dependent neural events in vivo remains mostly unknown and technically challenging to address because of the short half-life of these chemical messengers in the brain. Mice lacking the enzyme fatty acid amide hydrolase [FAAH (−/−) mice] are severely impaired in their ability to degrade the endocannabinoid anandamide and therefore represent a unique animal model in which to examine the function of this signaling lipid in vivo . Here, we show that the administration of anandamide dramatically augments the severity of chemically induced seizures in FAAH (−/−) mice but not in wild-type mice. Anandamide-enhanced seizures in FAAH (−/−) mice resulted in significant neuronal damage in the CA1 and CA3 regions of the hippocampus for the bicuculline an...
    May 1, 2003 Angela B. Clement
  • Abstract
    Cannabinoids change circadian timing and recruit astrocytes to modulate GABAergic neurotransmission within the SCN
    Aberrant endocannabinoid signaling is implicated in epilepsy, mood disorders, and neurodegenerative diseases, all of which frequently present with sleep/wake and circadian disturbances indicating that the endocannabinoid system may be involved in daily ...
    Nov 16, 2016
  • Abstract
    Cortisol levels and inhibitory control correlated with relapse on a group of addicts in rehab treatment
    Addiction is a chronic disease characterized by the compulsive use of drugs. The treatments are not very effective; in fact, 60%-70% of the addicts relapse in the first year of abstinence. Stress and inhibitory control are a risk factor in both consumpt...
    Nov 16, 2016
  • Abstract
    Anticonvulsant effect of cannabinoid receptor agonists in a model of neonatal seizures
    Neonatal seizures and seizures of infancy represent a significant cause of morbidity. 30-40% of infants and children with seizures will fail to achieve seizure remission with current anti-epileptic drug (AED) treatment. Moreover, less than half of elect...
    Nov 16, 2016
  • Abstract
    In vitro determination of the CB1 efficacy of illicit synthetic cannabinoids
    BACKGROUND AND PURPOSE: The rapid emergence of synthetic cannabinoids (SCs) as drugs of abuse poses a significant challenge to health care systems and policymakers worldwide. The morbidity and mortality associated with SC use highlights the need for a d...
    Nov 6, 2018
  • Abstract
    Characterization and modulation of human t-type calcium channels by synthetic cannabinoids in vitro
    T-type calcium channels (CaV3.X) are critical for many physiological processes, altering their activity contributes to disease states including cardiac arrhythmia, epilepsy and pain. Interestingly, clinical reports of some severe adverse reactions attri...
    Nov 4, 2018
  • Abstract
    Maternal cannabis vapor exposure dose-dependently impairs behavioral flexibility in adult offspring
    Cannabis is the most commonly used illicit substance among pregnant women, yet the effects of prenatal cannabis exposure on cognitive functioning in offspring remain largely unknown. With recreational cannabis laws now in effect in 8 states and counting...
    Nov 4, 2018
  • Previous
  • 60
  • 61
  • 62
  • 63
  • 64
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience